Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Moses

Showing results (251-260 of 292) with videos related to

Pageof 30
Sort By:
Scientific Reports|March 6, 2021
In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)Merricka C Livingstone, Alexis A Bitzer, Alish Giri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2013
Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responsesLaurent Verkoczy, Yao Chen, Jinsong Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 17, 2022
Nano-Theranostic Modality for Visualization of the Placenta and Photo-Hyperthermia for Potential Management of Ectopic PregnancyAbraham S Moses, Leena Kadam, Anna St Lorenz, et al.
Sexually Transmitted Infections|October 19, 2007
Evaluating large-scale HIV prevention interventions: study design for an integrated mathematical modelling approachM-C Boily, C M Lowndes, P Vickerman, et al.
Journal of Virology|September 16, 2011
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformationS Munir Alam, Hua-Xin Liao, S Moses Dennison, et al.
Journal of the American Chemical Society|August 7, 2013
Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccinesBaptiste Aussedat, Yusuf Vohra, Peter K Park, et al.
Plos Pathogens|September 1, 2016
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and SubclassesMatthew Zirui Tay, Pinghuang Liu, LaTonya D Williams, et al.
Theranostics|December 18, 2018
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNACanan Schumann, Duc X Nguyen, Mason Norgard, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestorsS Munir Alam, S Moses Dennison, Baptiste Aussedat, et al.
The Journal of Infectious Diseases|September 1, 2022
Identifying Paucisymptomatic or Asymptomatic and Unrecognized Ebola Virus Disease Among Close Contacts Based on Exposure Risk Assessments and Screening AlgorithmsDehkontee Gayedyu-Dennis, Mosoka P Fallah, Clara Drew, et al.
Pageof 30

Showing results (251-260 of 292) with videos related to

Sort By:
Pageof 30
Scientific Reports|March 6, 2021
In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)Merricka C Livingstone, Alexis A Bitzer, Alish Giri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2013
Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responsesLaurent Verkoczy, Yao Chen, Jinsong Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 17, 2022
Nano-Theranostic Modality for Visualization of the Placenta and Photo-Hyperthermia for Potential Management of Ectopic PregnancyAbraham S Moses, Leena Kadam, Anna St Lorenz, et al.
Sexually Transmitted Infections|October 19, 2007
Evaluating large-scale HIV prevention interventions: study design for an integrated mathematical modelling approachM-C Boily, C M Lowndes, P Vickerman, et al.
Journal of Virology|September 16, 2011
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformationS Munir Alam, Hua-Xin Liao, S Moses Dennison, et al.
Journal of the American Chemical Society|August 7, 2013
Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccinesBaptiste Aussedat, Yusuf Vohra, Peter K Park, et al.
Plos Pathogens|September 1, 2016
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and SubclassesMatthew Zirui Tay, Pinghuang Liu, LaTonya D Williams, et al.
Theranostics|December 18, 2018
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNACanan Schumann, Duc X Nguyen, Mason Norgard, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestorsS Munir Alam, S Moses Dennison, Baptiste Aussedat, et al.
The Journal of Infectious Diseases|September 1, 2022
Identifying Paucisymptomatic or Asymptomatic and Unrecognized Ebola Virus Disease Among Close Contacts Based on Exposure Risk Assessments and Screening AlgorithmsDehkontee Gayedyu-Dennis, Mosoka P Fallah, Clara Drew, et al.
Pageof 30